Terms: Byetta (132000), exenatide (70900), glycemic control (599000), incretin mimetic (763), incretin mimetics (1960), incretins (2370), incretin hormones (2870), incretin effect (569), incretin hormone (1300),
Incretin Mimetics - Backgrounder
PubMed Search Form at National Institutes of Health
Terms: gastric emptying (371000), promotion of satiety (63), rate of gastric emptying (1860),
Terms: glucagon-like peptide 1 (103000), GLP-1 (142000), GLP-1 analogs (424), GLP analogs (8), glucose homeostatis (77), pancreatic beta cell (125000), pancreatic beta cells (189000), gastric inhibitory polypeptide (22600), DPP-IV (40300), GIP receptors (227), exendin-4 (21200), Dipeptidyl Peptidase-IV (60500),
American Academy of Family Physicians
Boolean: byetta AND "weight loss" (24800), diabetes AND "weight loss" (19100000), byetta AND weight (46000),
Terms: appetite (28100000), loss of appetite (2430000), suppress appetite (199000), appetite suppression (219000), progressive weight reduction (144), cardiovascular risk factors (764000), greatest weight reduction (80), rapid gastrointestinal absorption (143), gastrointestinal absorption (72200),
Terms: awareness of hunger (2830), hungry (56300000), hunger pains (226000), awareness of thirst (51), thirsty (9830000), awareness of tiredness (4), tired (112000000), awareness of pain (9380), awareness of physical needs (13), dissociation (3550000), dissociative (1560000), autistic (10700000), body awareness (586000),
Byetta shows sustained improvements in glucose control and progressive weight reduction in patients with type 2 diabetes